Eva Renee Barnett, Chief Financial Officer at Immunovant, Inc. (IMVT), sold 12,500 shares at $9.44 ($118K) on 2022-10-11, disclosed to the SEC on 2022-10-13.
Open-market sale of $118k IMVT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| IMVT | SELL | 2025-02-21 | $117K | — | Filing → |
| IMVT | SELL | 2025-01-17 | $107K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $198K | — | Filing → |